Dow Down0.92% Nasdaq Down0.83%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
40.48 0.64(1.56%) Oct 22, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 147,285   102,049   99,086  
Cost of Revenue -   -   -  
Gross Profit 147,285   102,049   99,086  
Operating Expenses
Research Development184,033  158,458  157,397  
Selling General and Administrative14,918  12,515  12,789  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (51,666) (68,924) (71,100)
Income from Continuing Operations
Total Other Income/Expenses Net4,463  16,895  6,596  
Earnings Before Interest And Taxes(47,203)(53,435)(68,058)
Interest Expense19,355  21,152  16,732  
Income Before Tax(66,558)(74,587)(84,790)
Income Tax Expense(5,914)(9,109)11  
Minority Interest -   -   -  
Net Income From Continuing Ops(60,644)(71,654)(88,355)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (60,644) (65,478) (84,801)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (60,644) (65,478) (84,801)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.